An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
ENDRA Life Sciences Inc. (NASDAQ: NDRA) announced its upcoming financial results for the year ending December 31, 2022, set to be released on March 14, 2023, after U.S. market close. A conference call and webcast will commence at 4:30 p.m. Eastern time to discuss the results and provide updates on corporate developments. Participants can pre-register and access the call through provided links or by dialing specific numbers for U.S. and international callers. ENDRA is known for its innovative Thermo Acoustic Enhanced Ultrasound (TAEUS®) technology aimed at improving diagnostic tools for chronic liver diseases affecting over one billion patients globally.
Positive
ENDRA is a pioneer in Thermo Acoustic Enhanced Ultrasound (TAEUS®), targeting significant global health issues like liver diseases.
The company is positioned to provide cost-effective diagnostic solutions that can integrate with over 500,000 current ultrasound systems.
Negative
None.
ANN ARBOR, Mich.--(BUSINESS WIRE)--
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months and year ended December 31, 2022 on Tuesday, March 14, 2023 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer questions.
Participants are encouraged to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing (844) 868-8846 (U.S.) or (412) 317-5465 (International). A webcast of the call can also be accessed at ENDRA’s Investor Relations page and here.
A telephone replay will be available until March 21, 2023 by dialing (877) 344-7529 (U.S.) or (412) 317-0088 (International) and providing the passcode 2113040. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.
About ENDRA Life Sciences Inc.
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with over 500,000 ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.
When will ENDRA Life Sciences report its financial results for 2022?
ENDRA Life Sciences will report its financial results for the year ended December 31, 2022, on March 14, 2023.
What is the focus of ENDRA's TAEUS technology?
ENDRA's TAEUS technology focuses on visualizing liver fat to diagnose Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).
How can I access the conference call discussing ENDRA's financial results?
You can access the conference call by pre-registering via the provided link or by dialing the appropriate phone numbers for U.S. and international participants.
What time is the conference call for ENDRA's financial results?
The conference call will begin at 4:30 p.m. Eastern time on March 14, 2023.
What clinical applications is ENDRA exploring beyond liver diagnostics?
ENDRA is exploring other clinical applications of TAEUS, including tissue temperature visualization during energy-based surgical procedures.
